TI
IMVT icon

Trexquant Investment’s Immunovant IMVT Stock Holding History

Trexquant Investment’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$638K Sell
25,692
-89,303
-78% -$2.31M ﹤0.01% 1385
2025
Q4 		$2.92M Buy
+114,995
New +$2.56M 0.03% 833
2024
Q2 		– Sell
-58,218
Closed -$1.88M – 1674
2024
Q1 		$1.88M Buy
+58,218
New +$2.12M 0.04% 682
2023
Q4 		– Sell
-77,806
Closed -$2.99M – 1592
2023
Q3 		$2.99M Buy
+77,806
New +$1.76M 0.07% 367
2023
Q2 		– Sell
-34,184
Closed -$530K – 1594
2023
Q1 		$530K Sell
34,184
-43,208
-56% -$750K 0.01% 975
2022
Q4 		$1.37M Buy
+77,392
New +$974K 0.04% 534
2021
Q4 		– Sell
-18,198
Closed -$158K – 1444
2021
Q3 		$158K Buy
+18,198
New +$164K 0.01% 999

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return